These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3878119)

  • 41. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
    Sawami H; Toyokawa Y; Ito K; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
    Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
    J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic basis for immune dysfunction in adenosine deaminase deficiency.
    Carson DA; Iizasa T; Seto S; Carrera CJ; Kubota M; Willis EH; Wasson DB; Kajander O
    Ann N Y Acad Sci; 1985; 451():34-41. PubMed ID: 3878120
    [No Abstract]   [Full Text] [Related]  

  • 44. Expression of murine ADA cDNA in bacterial and mammalian cells.
    Ingolia DE; Yeung CY; Shoemaker C; Kaufman RJ; Kellems RE
    Adv Exp Med Biol; 1986; 195 Pt A():223-9. PubMed ID: 3524134
    [No Abstract]   [Full Text] [Related]  

  • 45. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 46. Identification of transcription stop sites at the 5' and 3' ends of the murine adenosine deaminase gene.
    Maa MC; Chinsky JM; Ramamurthy V; Martin BD; Kellems RE
    J Biol Chem; 1990 Jul; 265(21):12513-9. PubMed ID: 2373702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radioimmunochemical quantitation of human adenosine deaminase.
    Daddona PE; Frohman MA; Kelley WN
    J Clin Invest; 1979 Sep; 64(3):798-803. PubMed ID: 468994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency].
    Souillet G
    Pediatrie; 1975; 30(7):746-56. PubMed ID: 1105387
    [No Abstract]   [Full Text] [Related]  

  • 49. Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.
    Markert ML; Hutton JJ; Wiginton DA; States JC; Kaufman RE
    J Clin Invest; 1988 May; 81(5):1323-7. PubMed ID: 3366897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identical 3250-bp deletion between two AluI repeats in the ADA genes of unrelated ADA-SCID patients.
    Berkvens TM; van Ormondt H; Gerritsen EJ; Khan PM; van der Eb AJ
    Genomics; 1990 Aug; 7(4):486-90. PubMed ID: 1696926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency.
    Hirschhorn R; Martiniuk F; Rosen FS
    Clin Immunol Immunopathol; 1978 Mar; 9(3):287-92. PubMed ID: 627115
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetic expression in partial adenosine deaminase deficiency. mRNA levels and protein turnover for the enzyme variants in human B-lymphoblast cell lines.
    Daddona PE; Davidson BL; Perignon JL; Kelley WN
    J Biol Chem; 1985 Mar; 260(6):3875-80. PubMed ID: 3871777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 54. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
    Bordignon C; Yu SF; Smith CA; Hantzopoulos P; Ungers GE; Keever CA; O'Reilly RJ; Gilboa E
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6748-52. PubMed ID: 2549545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inherited immunodeficiency diseases: relationship to lymphocyte metabolic dysfunction.
    Giblett ER; Polmar SH
    Prog Med Genet; 1979; 3():177-219. PubMed ID: 118484
    [No Abstract]   [Full Text] [Related]  

  • 56. [Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Aug; 35(8):2564-80. PubMed ID: 411964
    [No Abstract]   [Full Text] [Related]  

  • 57. Enzyme defects in purine metabolism and immunodeficiencies.
    Ito K
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1764-71. PubMed ID: 3939170
    [No Abstract]   [Full Text] [Related]  

  • 58. Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
    Adrian GS; Hutton JJ
    J Clin Invest; 1983 Jun; 71(6):1649-60. PubMed ID: 6134754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene.
    Germann UA; Chin KV; Pastan I; Gottesman MM
    FASEB J; 1990 Mar; 4(5):1501-7. PubMed ID: 1968408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of normal and mutant adenosine deaminase messenger RNAs by translation and hybridization to a cDNA probe.
    Adrian GS; Wiginton DA; Hutton JJ
    Hum Genet; 1984; 68(2):169-72. PubMed ID: 6548726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.